A team of researchers at the University of Oxford have unveiled a pioneering "microstent" which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been ...

Please provide your email address to receive an email when new articles are posted on . Decreases in mental health scores after glaucoma diagnosis may be associated with fears of vision loss or ...

Glaucoma is a major public health issue in ophthalmology. Despite advances in diagnostics and treatment, it continues to be the leading cause of irreversible blindness worldwide1 and second in ...

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in ...

The total open-angle glaucoma treatment market size is expected to grow positively by 2034 in the leading markets (the US, EU4, UK, and Japan). In the US, approximately 80% of all glaucoma cases are ...

Glaucoma is usually a chronic condition that is typically associated with raised intraocular pressure (IOP). The most common type of glaucoma in the UK is primary open-angle glaucoma. It leads to ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...

MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing ...